In addition, to elucidate the roles of CD44 in anti‐VEGF therapy, we performed in vitro and in vivo studies using glioma stem‐like cells (GSCs) and a GSC‐transplanted mouse xenograft model, respectively. The gene discussed is CD44; the disease is central nervous system cancer.